Clinical trial finds azithromycin pills equal to penicillin shots for treating early syphilis

Jun 01, 2010

In a clinical trial involving HIV-negative volunteers with early-stage syphilis, researchers have found that antibiotic pills (azithromycin) are as effective as penicillin injections in curing early-stage syphilis. The study was supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

Edward W. Hook, III, M.D., of the University of Alabama at Birmingham, led the trial. Between June 2000 and March 2007, HIV-negative volunteers aged 18 to 55 enrolled at eight sites in the United States and Madagascar. Volunteers were randomly assigned to receive either two injections of benzathine G or four tablets of the broad-spectrum antimicrobial macrolide drug azithromycin. Of 517 total enrollees, 469 were included in an intention-to-treat analysis. Among azithromycin recipients, 77.6 percent (180 out of 232) were cured of syphilis, while cure rate among penicillin recipients was 78.5 percent (186 out of 237).

Although long-acting penicillin delivered by injection is recommended as the preferred treatment for early syphilis, the authors note that this therapy has shortcomings, particularly in resource-limited settings. Penicillin injections can cause allergic reactions, and the drug must be refrigerated and administrated by trained personnel. The orally administered azithromycin may provide a good alternative for treating HIV-negative people with early-stage syphilis, the scientists conclude. They note that there is a potential for syphilis-causing to acquire resistance to macrolide drugs such as azithromycin and they recommend continued research into this possibility.

Detailed information about the study's design is available at clinicaltrials.gov.

Explore further: 5 things to know about Ebola outbreak in W. Africa

More information: EW Hook et al. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. Journal of Infectious Diseases DOI: 10.1086/652239 (2010).

Provided by National Institutes of Health

not rated yet
add to favorites email to friend print save as pdf

Related Stories

NYC syphilis cases double in first quarter of 2007

Jul 09, 2007

After leveling off for more than two years, and declining in 2006, new syphilis cases spiked in New York City during the first three months of 2007. The Health Department announced today that doctors reported 260 cases of ...

Syphilis making a comeback

May 09, 2007

Three years after Virginia public health officials thought syphilis was almost eradicated, the disease has surged, with the number of cases doubling.

Scientists discover how some bacteria survive antibiotics

Apr 30, 2008

Researchers at the University of Illinois at Chicago have discovered how some bacteria can survive antibiotic treatment by turning on resistance mechanisms when exposed to the drugs. The findings, published in the April 24 ...

Recommended for you

$1,000 pill now hepatitis C treatment of choice

3 hours ago

(AP)—A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans.

5 things to know about Ebola outbreak in W. Africa

16 hours ago

(AP)—There has been panic and fear about the deadly Ebola disease spreading ever since Nigerian health officials reported Friday that a Liberian man sick with the disease had traveled to Togo and then Nigeria ...

User comments : 0